BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu L, Liu J, Hou J, Zhan T, Yuan L, Liu F, Xiong Y, Hu J, Xia C. Interactions of the major effective components in Shengmai formula with breast cancer resistance protein at the cellular and vesicular levels. Biomedicine & Pharmacotherapy 2021;133:110939. [DOI: 10.1016/j.biopha.2020.110939] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan B, Shi R, Lu YY, Fang DD, Ye MN, Zhou QM. Shenqi Fuzheng injection reverses M2 macrophage-mediated cisplatin resistance through the PI3K pathway in breast cancer. PLoS One 2023;18:e0279752. [PMID: 36693064 DOI: 10.1371/journal.pone.0279752] [Reference Citation Analysis]
2 Hou J, Zhong L, Liu J, Liu F, Xia C. Interaction of the main active components in Shengmai formula mediated by organic anion transporter 1 (OAT1). J Ethnopharmacol 2022;:115515. [PMID: 35777609 DOI: 10.1016/j.jep.2022.115515] [Reference Citation Analysis]
3 Sun Q, Li L, Zhou Q. Effects of Ethanolic Extract of Schisandra sphenanthera on the Pharmacokinetics of Rosuvastatin in Rats. DDDT 2022;Volume 16:1473-1481. [DOI: 10.2147/dddt.s364234] [Reference Citation Analysis]
4 Xu JF, Wan Y, Tang F, Chen L, Yang Y, Xia J, Wu JJ, Ao H, Peng C. Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy. Front Pharmacol 2021;12:720474. [PMID: 34975466 DOI: 10.3389/fphar.2021.720474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Auxtero MD, Chalante S, Abade MR, Jorge R, Fernandes AI. Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction. Pharmaceutics 2021;13:124. [PMID: 33478035 DOI: 10.3390/pharmaceutics13010124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]